N. Altin Et Al. , "Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.," Journal of medical virology , 2022
Altin, N. Et Al. 2022. Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.. Journal of medical virology .
Altin, N., Altay, F. A., Albayrak, M., Sahingoz, S. O., & Sencan, I., (2022). Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.. Journal of medical virology .
Altin, Nilgun Et Al. "Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.," Journal of medical virology , 2022
Altin, Nilgun Et Al. "Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.." Journal of medical virology , 2022
Altin, N. Et Al. (2022) . "Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.." Journal of medical virology .
@article{article, author={Nilgun Altin Et Al. }, title={Serum thrombin-activatable fibrinolysis inhibitor levels and its relation with pathogenesis and bleeding and prognosis in patients with Crimean Congo hemorrhagic fever.}, journal={Journal of medical virology}, year=2022}